Skip to main content
Clinical Trials/NCT03980743
NCT03980743
Completed
Not Applicable

Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Early Serious Mental Illness: iOTA-eSMI

Washington University School of Medicine2 sites in 1 country51 target enrollmentJuly 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Washington University School of Medicine
Enrollment
51
Locations
2
Primary Endpoint
Body Mass Index
Status
Completed
Last Updated
last year

Overview

Brief Summary

Using a design-for-dissemination approach, this application proposes to use combined methods to adapt and pilot test an interactive obesity treatment approach (iOTA) for obesity prevention in early serious mental illness (eSMI) that uses text messaging to provide between-visit support. Derived from the lifestyle intervention used in the Diabetes Prevention Program, the parent iOTA targets diet, activity and adherence using web-based and health coach support.

Detailed Description

Most obesity and related complications in serious mental illness (SMI) occur in the context of chronic psychiatric illness, but there are few treatments that work. Behavioral interventions face challenges with long-term effectiveness, implementation and sustainability. Medications have modest effectiveness at best, and/or pose serious side effect risks. This study focuses on prevention of chronic obesity by adapting and pilot testing a prevention-focused, interactive obesity treatment approach (iOTA) for use in persons with early-phase SMI (eSMI) experiencing initial weight gain, overweight or early-stage obesity. The intervention will be adapted from the most studied, effective iOTA, derived from the Diabetes Prevention Program. The parent iOTA uses health coaches who extend their sustainable reach with scalable, inexpensive, semi-automated text messaging. Using a formal evaluation process and a specific implementation science framework, planned adaptations for this application will address mechanisms to improve health-related awareness, insight and self-efficacy skills. Aim 1: Evaluate barriers and facilitators for intervention engagement, effectiveness and implementation, and identify needed adaptations of the prior iOTA for use in obesity attenuation in eSMI. Aim 2: Adapt the prior iOTA for use in obesity attenuation in eSMI, aiming to maximize acceptability, engagement, sustainable reach and target engagement for eSMI. Aim 3: Conduct a randomized pilot and feasibility study of iOTA-eSMI in a diverse sample of adults aged 18-45 with eSMI and initial weight gain, overweight or early class I obesity, comparing iOTA-eSMI to a health education condition.

Registry
clinicaltrials.gov
Start Date
July 15, 2020
End Date
May 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-60 years
  • At-risk weight defined as greater than 7 percent weight gain in the prior 2 years, overweight as evidenced by BMI 25-29.9, OR class I obesity as evidenced by BMI 30-32.49
  • Serious Mental Illness diagnosis
  • Receiving case management services
  • University of California, San Diego Brief Assessment of Capacity to Consent score less than 14
  • Not taking weight loss medications or participating in another behavioral weight loss intervention
  • Mild to moderate psychiatric symptom severity as measured by the Clinical Global Impression Severity scale
  • Willing and able to provide written informed consent
  • Exclusion criteria:
  • Taking weight loss medications or participating in another behavioral weight loss intervention

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Body Mass Index

Time Frame: baseline and 24 weeks

weight in kilograms/height in meters squared

Secondary Outcomes

  • Change in Self-Efficacy for Diet and Exercise(Baseline and 24 weeks)
  • Change in Psychophysical Skills & Insight(Baseline and 24 weeks)

Study Sites (2)

Loading locations...

Similar Trials